Track the Alpha Tau Medical Ltd. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.4bn. The latest transaction was reported on 25 August 2026 (Levée d'options). Among the most active insiders: Levy Raphi. All data is free.
24
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€786,180
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alpha Tau Medical Ltd. Buy (bullish), based on 5 analysts. Average price target: US$14.40.
30Σ signal
Buys n/a€786,180 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
15,000 shares@ US$10.757145.8% of flowOrdinary SharesSEC:0001213900-26-065201:1
24 of 24 declarations
Acerca de Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. es una empresa centrada en el desarrollo de tratamientos innovadores contra el cáncer utilizando tecnología de terapia de radiación alfa. Cotiza en NASDAQ bajo el ticker ATOU.